SCHEMBL28129241

SCHEMBL28129241

O=COc1ccccc1-c1ccccn1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA1D P25100 1/20 0.46
ADRA1A P35348 1/20 0.46
ADRA1B P35368 1/20 0.46
KDM4E B2RXH2 6/20 0.45
LMNA P02545 3/20 0.45
CCR1 P32246 2/20 0.45
CCR5 P51681 2/20 0.45
CCR8 P51685 2/20 0.45
CYP1A2 P05177 1/20 0.45
POLB P06746 1/20 0.45
METAP1 P53582 1/20 0.45
BLM P54132 1/20 0.45
HIF1A Q16665 1/20 0.45
DOHH Q9BU89 1/20 0.45
P4HTM Q9NXG6 1/20 0.45
GRM4 Q14833 1/20 0.44
CBFB Q13951 1/20 0.43
ADRA2A P08913 1/20 0.43
ADRA2B P18089 1/20 0.43
ADRA2C P18825 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28264423 0.89 ERN1 (0.43) ADRA1DADRA1AADRA1BKDM4ELMNA
SCHEMBL18228878 0.82 ADRA2A (0.46) ADRA1DADRA1AADRA1BKDM4ELMNA
SCHEMBL7196588 0.79 KDM4E (0.54) ADRA1DADRA1AADRA1BKDM4ELMNA
SCHEMBL18654154 0.76 KDM4E (0.50) ADRA1DADRA1AADRA1BKDM4ELMNA
SCHEMBL2039527 0.76 SMN1; SMN2 (0.62) ADRA1DADRA1AADRA1BKDM4ELMNA
SCHEMBL24677590 0.76 KDM4E (0.50) ADRA1DADRA1AADRA1BKDM4ELMNA
SCHEMBL29496935 0.76 SMN1; SMN2 (0.62) ADRA1DADRA1AADRA1BKDM4ELMNA
SCHEMBL18976884 0.76 KDM4E (0.50) ADRA1DADRA1AADRA1BKDM4ELMNA
SCHEMBL27684365 0.73 CYP1A2 (0.38) ADRA1DADRA1AADRA1BKDM4ELMNA
SCHEMBL1639618 0.73 CYP1A2 (0.46) ADRA1DADRA1AADRA1BKDM4ECYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106459087-B Process for the preparation of activated blood coagulation factor X (FXa) inhibitors 第三共株式会社 2019-04-09 CN disclosed
CN-106459087-A Process for the preparation of activated blood coagulation factor X (FXa) inhibitors 第三共株式会社 2017-02-22 CN disclosed